Purpose of review Coronary artery disease remains the most common cause of death
worldwide. In patients with biomarker-positive acute coronary syndrome, the combination of …

The recent publication of the Atorvastatin Versus Revascularization Treatment (AVERT) trial
has renewed debate on the optimal management strategy for relatively stable patients with …

Defining optimal management of patients with stable coronary artery disease continues to
be a central area of debate. While it has been established that all patients with coronary …

Introduction: Coronary artery disease (CAD) is the leading cause of mortality in developed
countries. Angina, myocardial infarction, heart failure and other clinical manifestations of …

Patients with coronary artery disease who have prognostically significant lesions or
symptoms despite optimum medical therapy require mechanical revascularization with …

Medical treatment is the initial treatmentstrategy and is the cornerstone of management in
patients with stable ischemicheart disease (IHD). Many patients are not suitable for …

OBJECTIVE: We sought to assess determinants of clinical decision making in patients with
stable coronary artery disease. METHODS: The 2936 patients with stable angina pectoris …

Objectives In stable coronary artery disease (CAD), coronary revascularisation may reduce
mortality of patients with a certain amount of left ventricular myocardial ischaemia. However …

The treatment of patients with stable angina has three goals: 1) minimize or eliminate
ischemia (silent or symptomatic), 2) reduce morbidity, and 3) decrease mortality. Surgical …

The objective of this study was to assess long-term clinical outcomes and their correlates in
medically managed outpatients with stable angina pectoris, healed myocardial infarction …